Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease

We previously observed that inflammatory bowel disease (IBD) may compromise oral host defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and myeloperoxidase (MPO). Biologic therapy with inhibitors of cytokines or adhesion molecules is increasingly used for patients with IBD....

Descripción completa

Detalles Bibliográficos
Autores principales: Nijakowski, Kacper, Rutkowski, Rafał, Eder, Piotr, Korybalska, Katarzyna, Witowski, Janusz, Surdacka, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708388/
https://www.ncbi.nlm.nih.gov/pubmed/34947940
http://dx.doi.org/10.3390/life11121409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708388/
https://www.ncbi.nlm.nih.gov/pubmed/34947940
http://dx.doi.org/10.3390/life11121409

Ejemplares similares